nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—NR3C1—urine—nephrolithiasis	0.042	0.122	CbGeAlD
Mifepristone—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0355	0.0542	CcSEcCtD
Mifepristone—CYP3A4—urine—nephrolithiasis	0.0317	0.092	CbGeAlD
Mifepristone—CYP2D6—urine—nephrolithiasis	0.0312	0.0906	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.0275	0.0797	CbGeAlD
Mifepristone—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0249	0.038	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0247	0.0377	CcSEcCtD
Mifepristone—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0247	0.0377	CcSEcCtD
Mifepristone—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0245	0.0373	CcSEcCtD
Mifepristone—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.0235	0.0683	CbGeAlD
Mifepristone—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0233	0.0355	CcSEcCtD
Mifepristone—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0323	CcSEcCtD
Mifepristone—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.021	0.0321	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.021	0.032	CcSEcCtD
Mifepristone—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.021	0.032	CcSEcCtD
Mifepristone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0205	0.0313	CcSEcCtD
Mifepristone—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0257	CcSEcCtD
Mifepristone—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0242	CcSEcCtD
Mifepristone—AR—renal system—nephrolithiasis	0.0142	0.0411	CbGeAlD
Mifepristone—AR—kidney—nephrolithiasis	0.0137	0.0397	CbGeAlD
Mifepristone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0207	CcSEcCtD
Mifepristone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0206	CcSEcCtD
Mifepristone—AR—cortex of kidney—nephrolithiasis	0.0133	0.0387	CbGeAlD
Mifepristone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.013	0.0199	CcSEcCtD
Mifepristone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0196	CcSEcCtD
Mifepristone—ABCC1—cortex of kidney—nephrolithiasis	0.0127	0.0368	CbGeAlD
Mifepristone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0193	CcSEcCtD
Mifepristone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0182	CcSEcCtD
Mifepristone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0182	CcSEcCtD
Mifepristone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0182	CcSEcCtD
Mifepristone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0118	0.018	CcSEcCtD
Mifepristone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0178	CcSEcCtD
Mifepristone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0175	CcSEcCtD
Mifepristone—CYP3A5—nephron tubule—nephrolithiasis	0.0114	0.033	CbGeAlD
Mifepristone—NR3C1—nephron tubule—nephrolithiasis	0.0113	0.0328	CbGeAlD
Mifepristone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0167	CcSEcCtD
Mifepristone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0163	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0159	CcSEcCtD
Mifepristone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0158	CcSEcCtD
Mifepristone—CYP3A5—renal system—nephrolithiasis	0.0103	0.03	CbGeAlD
Mifepristone—NR3C1—renal system—nephrolithiasis	0.0103	0.0298	CbGeAlD
Mifepristone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0156	CcSEcCtD
Mifepristone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0155	CcSEcCtD
Mifepristone—CYP3A5—kidney—nephrolithiasis	0.01	0.029	CbGeAlD
Mifepristone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00995	0.0152	CcSEcCtD
Mifepristone—NR3C1—kidney—nephrolithiasis	0.00992	0.0288	CbGeAlD
Mifepristone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00987	0.0151	CcSEcCtD
Mifepristone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00979	0.0149	CcSEcCtD
Mifepristone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00979	0.0149	CcSEcCtD
Mifepristone—CYP3A5—cortex of kidney—nephrolithiasis	0.00974	0.0283	CbGeAlD
Mifepristone—NR3C1—cortex of kidney—nephrolithiasis	0.00966	0.028	CbGeAlD
Mifepristone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00943	0.0144	CcSEcCtD
Mifepristone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00936	0.0143	CcSEcCtD
Mifepristone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00909	0.0139	CcSEcCtD
Mifepristone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00905	0.0138	CcSEcCtD
Mifepristone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00905	0.0138	CcSEcCtD
Mifepristone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00843	0.0129	CcSEcCtD
Mifepristone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00821	0.0125	CcSEcCtD
Mifepristone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0081	0.0124	CcSEcCtD
Mifepristone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00783	0.012	CcSEcCtD
Mifepristone—CYP3A4—renal system—nephrolithiasis	0.00776	0.0225	CbGeAlD
Mifepristone—CYP2D6—renal system—nephrolithiasis	0.00764	0.0222	CbGeAlD
Mifepristone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00757	0.0116	CcSEcCtD
Mifepristone—CYP3A4—kidney—nephrolithiasis	0.0075	0.0218	CbGeAlD
Mifepristone—CYP2D6—kidney—nephrolithiasis	0.00738	0.0214	CbGeAlD
Mifepristone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00728	0.0111	CcSEcCtD
Mifepristone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00722	0.011	CcSEcCtD
Mifepristone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00721	0.011	CcSEcCtD
Mifepristone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00717	0.0109	CcSEcCtD
Mifepristone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0068	0.0104	CcSEcCtD
Mifepristone—ABCB1—nephron tubule—nephrolithiasis	0.00604	0.0175	CbGeAlD
Mifepristone—ABCB1—renal system—nephrolithiasis	0.00549	0.0159	CbGeAlD
Mifepristone—ABCB1—kidney—nephrolithiasis	0.00531	0.0154	CbGeAlD
Mifepristone—ABCB1—cortex of kidney—nephrolithiasis	0.00517	0.015	CbGeAlD
